Global Neurological Disorder Drugs Market 2020 by Manufacturers, Type and Application, Forecast to 2025

  • receipt Report ID : 4295
  • calendar_today Published On: Jul, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The global Neurological Disorder Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 22730 million by 2025, from USD 19820 million in 2019.

The Neurological Disorder Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Neurological Disorder Drugs market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Neurological Disorder Drugs market has been segmented into Antipsychotic, Hypnotic & Sedative, Analgesics, Anticoagulants, Others, etc.

Breakdown by Application, Neurological Disorder Drugs has been segmented into Hospital, Clinic, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurological Disorder Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurological Disorder Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurological Disorder Drugs market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Neurological Disorder Drugs Market Share Analysis

Neurological Disorder Drugs competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Neurological Disorder Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neurological Disorder Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Neurological Disorder Drugs are: Novartis AG, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical, Merck & Co., Boehringer Ingelheim GmbH, AstraZeneca, etc. Among other players domestic and global, Neurological Disorder Drugs market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Neurological Disorder Drugs market are listed below:

Novartis AG

Bayer AG

GlaxoSmithKline plc

Teva Pharmaceutical

Merck & Co.

Boehringer Ingelheim GmbH

AstraZeneca

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Antipsychotic

Hypnotic & Sedative

Analgesics

Anticoagulants

Others

Market segment by Application, can be divided into

Hospital

Clinic

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Neurological Disorder Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Neurological Disorder Drugs Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Antipsychotic

1.2.3 Hypnotic & Sedative

1.2.4 Analgesics

1.2.5 Anticoagulants

1.2.6 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Neurological Disorder Drugs Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Neurological Disorder Drugs Market Size and Forecast (2015-2025)

1.4.1 Global Neurological Disorder Drugs Revenue and Forecast (2015-2025)

1.4.2 Global Neurological Disorder Drugs Sales and Forecast (2015-2025)

1.5 Global Neurological Disorder Drugs Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 Novartis AG

2.1.1 Novartis AG Details

2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Novartis AG SWOT Analysis

2.1.4 Novartis AG Product and Services

2.1.5 Novartis AG Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Bayer AG

2.2.1 Bayer AG Details

2.2.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Bayer AG SWOT Analysis

2.2.4 Bayer AG Product and Services

2.2.5 Bayer AG Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 GlaxoSmithKline plc

2.3.1 GlaxoSmithKline plc Details

2.3.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 GlaxoSmithKline plc SWOT Analysis

2.3.4 GlaxoSmithKline plc Product and Services

2.3.5 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Teva Pharmaceutical

2.4.1 Teva Pharmaceutical Details

2.4.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Teva Pharmaceutical SWOT Analysis

2.4.4 Teva Pharmaceutical Product and Services

2.4.5 Teva Pharmaceutical Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Merck & Co.

2.5.1 Merck & Co. Details

2.5.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Merck & Co. SWOT Analysis

2.5.4 Merck & Co. Product and Services

2.5.5 Merck & Co. Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Boehringer Ingelheim GmbH

2.6.1 Boehringer Ingelheim GmbH Details

2.6.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Boehringer Ingelheim GmbH SWOT Analysis

2.6.4 Boehringer Ingelheim GmbH Product and Services

2.6.5 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 AstraZeneca

2.7.1 AstraZeneca Details

2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 AstraZeneca SWOT Analysis

2.7.4 AstraZeneca Product and Services

2.7.5 AstraZeneca Neurological Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Neurological Disorder Drugs Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Neurological Disorder Drugs Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Neurological Disorder Drugs Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: United States

3.2.1 Key Players Neurological Disorder Drugs Sales in United States (2018-2019)

3.2.2 United States Neurological Disorder Drugs Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Neurological Disorder Drugs Manufacturer Market Share in 2019

3.3.2 Top 6 Neurological Disorder Drugs Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Neurological Disorder Drugs Market Size by Geography (2015-2020)

4.1.1 Global Neurological Disorder Drugs Sales by Geography (2015-2020)

4.1.2 Global Neurological Disorder Drugs Revenue by Regions (2015-2020)

4.2 Global Neurological Disorder Drugs Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Neurological Disorder Drugs Sales and Forecast by Regions (2020-2025)

4.2.2 Global Neurological Disorder Drugs Revenue and Forecast by Regions (2020-2025)

4.3 North America Neurological Disorder Drugs Market Size and Forecast (2015-2025)

4.4 Europe Neurological Disorder Drugs Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Neurological Disorder Drugs Market Size and Forecast (2015-2025)

4.6 South America Neurological Disorder Drugs Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Neurological Disorder Drugs Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Neurological Disorder Drugs Market Size by Country (2015-2020)

5.1.1 North America Neurological Disorder Drugs Sales and Market Share by Country (2015-2020)

5.1.2 North America Neurological Disorder Drugs Revenue and Market Share by Country (2015-2020)

5.2 North America Neurological Disorder Drugs Market Size and Forecast by Country (2020-2025)

5.2.1 North America Neurological Disorder Drugs Sales and Forecast by Country (2020-2025)

5.2.2 North America Neurological Disorder Drugs Revenue and Forecast by Country (2020-2025)

5.3 United States Neurological Disorder Drugs Market Size and Forecast (2015-2025)

5.4 Canada Neurological Disorder Drugs Market Size and Forecast (2015-2025)

5.5 Mexico Neurological Disorder Drugs Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Neurological Disorder Drugs Market Size by Country (2015-2020)

6.1.1 Europe Neurological Disorder Drugs Sales by Country (2015-2020)

6.1.2 Europe Neurological Disorder Drugs Revenue by Country (2015-2020)

6.2 Europe Neurological Disorder Drugs Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Neurological Disorder Drugs Sales and Forecast by Country (2020-2025)

6.2.2 Europe Neurological Disorder Drugs Revenue and Forecast by Country (2020-2025)

6.3 Germany Neurological Disorder Drugs Market Size and Forecast (2015-2025)

6.4 United Kingdom Neurological Disorder Drugs Market Size and Forecast (2015-2025)

6.5 France Neurological Disorder Drugs Market Size and Forecast (2015-2025)

6.6 Russia Neurological Disorder Drugs Market Size and Forecast (2015-2025)

6.7 Italy Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Neurological Disorder Drugs Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Neurological Disorder Drugs Sales by Region (2015-2020)

7.1.2 Asia-Pacific Neurological Disorder Drugs Revenue by Region (2015-2020)

7.2 Asia-Pacific Neurological Disorder Drugs Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Neurological Disorder Drugs Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Neurological Disorder Drugs Revenue and Forecast by Region (2020-2025)

7.3 China Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7.4 Japan Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7.5 Korea Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7.6 India Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7.7 Southeast Asia Neurological Disorder Drugs Market Size and Forecast (2015-2025)

7.8 Australia Neurological Disorder Drugs Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Neurological Disorder Drugs Market Size by Country (2015-2020)

8.1.1 South America Neurological Disorder Drugs Sales by Country (2015-2020)

8.1.2 South America Neurological Disorder Drugs Revenue by Country (2015-2020)

8.2 South America Neurological Disorder Drugs Market Size and Forecast by Country (2020-2025)

8.2.1 South America Neurological Disorder Drugs Sales and Forecast by Country (2020-2025)

8.2.2 South America Neurological Disorder Drugs Revenue and Forecast by Country (2020-2025)

8.3 Brazil Neurological Disorder Drugs Market Size and Forecast (2015-2025)

8.4 Argentina Neurological Disorder Drugs Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Neurological Disorder Drugs Sales by Country (2015-2020)

9.1.2 Middle East & Africa Neurological Disorder Drugs Revenue by Country (2015-2020)

9.2 Middle East & Africa Neurological Disorder Drugs Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Neurological Disorder Drugs Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Neurological Disorder Drugs Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Neurological Disorder Drugs Market Size and Forecast (2015-2025)

9.4 Turkey Neurological Disorder Drugs Market Size and Forecast (2015-2025)

9.5 Egypt Neurological Disorder Drugs Market Size and Forecast (2015-2025)

9.6 South Africa Neurological Disorder Drugs Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Neurological Disorder Drugs Market Size by Type (2015-2020)

10.1.1 Global Neurological Disorder Drugs Sales by Type (2015-2020)

10.1.2 Global Neurological Disorder Drugs Revenue by Type (2015-2020)

10.1.3 Global Neurological Disorder Drugs Price by Type (2015-2020)

10.2 Global Neurological Disorder Drugs Market Size and Forecast by Type (2020-2025)

10.2.1 Global Neurological Disorder Drugs Sales and Forecast by Type (2020-2025)

10.2.2 Global Neurological Disorder Drugs Revenue and Forecast by Type (2020-2025)

10.2.3 Global Neurological Disorder Drugs Price and Forecast by Type (2020-2025)

10.3 United States Neurological Disorder Drugs Market Size and Forecast by Type (2015-2025)

10.3.1 United States Neurological Disorder Drugs Market Size by Type (2015-2020)

10.3.2 United States Neurological Disorder Drugs Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Neurological Disorder Drugs Market Size by Application (2015-2020)

11.1.1 Global Neurological Disorder Drugs Sales by Application (2015-2020)

11.1.2 Global Neurological Disorder Drugs Revenue by Application (2015-2020)

11.1.3 Global Neurological Disorder Drugs Price by Application (2015-2020)

11.2 Global Neurological Disorder Drugs Market Size and Forecast by Application (2020-2025)

11.2.1 Global Neurological Disorder Drugs Sales and Forecast by Application (2020-2025)

11.2.2 Global Neurological Disorder Drugs Revenue and Forecast by Application (2020-2025)

11.2.3 Global Neurological Disorder Drugs Price and Forecast by Application (2020-2025)

11.3 United States Neurological Disorder Drugs Market Size and Forecast by Application (2015-2025)

11.3.1 United States Neurological Disorder Drugs Market Size by Application (2015-2020)

11.3.2 United States Neurological Disorder Drugs Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Neurological Disorder Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Neurological Disorder Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Neurological Disorder Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Neurological Disorder Drugs Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Novartis AG Basic Information, Manufacturing Base and Competitors

Table 6. Novartis AG Neurological Disorder Drugs Major Business

Table 7. Novartis AG Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 8. Novartis AG SWOT Analysis

Table 9. Novartis AG Neurological Disorder Drugs Product and Services

Table 10. Novartis AG Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors

Table 12. Bayer AG Neurological Disorder Drugs Major Business

Table 13. Bayer AG Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 14. Bayer AG SWOT Analysis

Table 15. Bayer AG Neurological Disorder Drugs Product and Services

Table 16. Bayer AG Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 17. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors

Table 18. GlaxoSmithKline plc Neurological Disorder Drugs Major Business

Table 19. GlaxoSmithKline plc Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 20. GlaxoSmithKline plc SWOT Analysis

Table 21. GlaxoSmithKline plc Neurological Disorder Drugs Product and Services

Table 22. GlaxoSmithKline plc Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 24. Teva Pharmaceutical Neurological Disorder Drugs Major Business

Table 25. Teva Pharmaceutical Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 26. Teva Pharmaceutical SWOT Analysis

Table 27. Teva Pharmaceutical Neurological Disorder Drugs Product and Services

Table 28. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 29. Merck & Co. Basic Information, Manufacturing Base and Competitors

Table 30. Merck & Co. Neurological Disorder Drugs Major Business

Table 31. Merck & Co. Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 32. Merck & Co. SWOT Analysis

Table 33. Merck & Co. Neurological Disorder Drugs Product and Services

Table 34. Merck & Co. Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 35. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors

Table 36. Boehringer Ingelheim GmbH Neurological Disorder Drugs Major Business

Table 37. Boehringer Ingelheim GmbH Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 38. Boehringer Ingelheim GmbH SWOT Analysis

Table 39. Boehringer Ingelheim GmbH Neurological Disorder Drugs Product and Services

Table 40. Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 41. AstraZeneca Basic Information, Manufacturing Base and Competitors

Table 42. AstraZeneca Neurological Disorder Drugs Major Business

Table 43. AstraZeneca Neurological Disorder Drugs Total Revenue (USD Million) (2018-2019)

Table 44. AstraZeneca SWOT Analysis

Table 45. AstraZeneca Neurological Disorder Drugs Product and Services

Table 46. AstraZeneca Neurological Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 47. Global Neurological Disorder Drugs Sales by Manufacturer (2018-2019) (K Units)

Table 48. Global Neurological Disorder Drugs Revenue by Manufacturer (2018-2019) (USD Million)

Table 49. Key Players Neurological Disorder Drugs Sales in United States (2018-2019) (K Units)

Table 50. Key Players Neurological Disorder Drugs Sales Market Share in United States (2018-2019)

Table 51. Key Players Revenue of Neurological Disorder Drugs in United States (2018-2019) (USD Million)

Table 52. Global Neurological Disorder Drugs Sales by Regions (2015-2020) (K Units)

Table 53. Global Neurological Disorder Drugs Sales Market Share by Regions (2015-2020)

Table 54. Global Neurological Disorder Drugs Revenue by Regions (2015-2020) (USD Million)

Table 55. Global Neurological Disorder Drugs Sales and Forecast by Regions (2020-2025) (K Units)

Table 56. Global Neurological Disorder Drugs Sales Market Share by Regions (2020-2025)

Table 57. Global Neurological Disorder Drugs Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 58. Global Neurological Disorder Drugs Revenue Market Share by Regions (2020-2025) (USD Million)

Table 59. North America Neurological Disorder Drugs Sales by Countries (2015-2020) (K Units)

Table 60. North America Neurological Disorder Drugs Sales Market Share by Countries (2015-2020)

Table 61. North America Neurological Disorder Drugs Revenue by Countries (2015-2020) (USD Million)

Table 62. North America Neurological Disorder Drugs Revenue Market Share by Countries (2015-2020)

Table 63. North America Neurological Disorder Drugs Sales by Country (2020-2025) (K Units)

Table 64. North America Neurological Disorder Drugs Sales Market Share by Country (2020-2025)

Table 65. North America Neurological Disorder Drugs Revenue by Country (2020-2025) (USD Million)

Table 66. North America Neurological Disorder Drugs Revenue Market Share by Country (2020-2025)

Table 67. Europe Neurological Disorder Drugs Sales by Countries (2015-2020) (K Units)

Table 68. Europe Neurological Disorder Drugs Sales Market Share by Countries (2015-2020)

Table 69. Europe Neurological Disorder Drugs Revenue by Countries (2015-2020) (USD Million)

Table 70. Europe Neurological Disorder Drugs Revenue Market Share by Countries (2015-2020)

Table 71. Europe Neurological Disorder Drugs Sales by Country (2020-2025) (K Units)

Table 72. Europe Neurological Disorder Drugs Sales Market Share by Country (2020-2025)

Table 73. Europe Neurological Disorder Drugs Revenue by Country (2020-2025) (USD Million)

Table 74. Europe Neurological Disorder Drugs Revenue Market Share by Country (2020-2025)

Table 75. Asia-Pacific Neurological Disorder Drugs Sales by Countries (2015-2020) (K Units)

Table 76. Asia-Pacific Neurological Disorder Drugs Sales Market Share by Countries (2015-2020)

Table 77. Asia-Pacific Neurological Disorder Drugs Revenue by Countries (2015-2020) (USD Million)

Table 78. Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Countries (2015-2020)

Table 79. Asia-Pacific Neurological Disorder Drugs Sales by Country (2020-2025) (K Units)

Table 80. Asia-Pacific Neurological Disorder Drugs Sales Market Share by Country (2020-2025)

Table 81. Asia-Pacific Neurological Disorder Drugs Revenue by Country (2020-2025) (USD Million)

Table 82. Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Country (2020-2025)

Table 83. South America Neurological Disorder Drugs Sales by Countries (2015-2020) (K Units)

Table 84. South America Neurological Disorder Drugs Sales Market Share by Countries (2015-2020)

Table 85. South America Neurological Disorder Drugs Revenue by Countries (2015-2020) (USD Million)

Table 86. South America Neurological Disorder Drugs Revenue Market Share by Countries (2015-2020)

Table 87. South America Neurological Disorder Drugs Sales by Country (2020-2025) (K Units)

Table 88. South America Neurological Disorder Drugs Sales Market Share by Country (2020-2025)

Table 89. South America Neurological Disorder Drugs Revenue by Country (2020-2025) (USD Million)

Table 90. South America Neurological Disorder Drugs Revenue Market Share by Country (2020-2025)

Table 91. Middle East & Africa Neurological Disorder Drugs Sales by Countries (2015-2020) (K Units)

Table 92. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Countries (2015-2020)

Table 93. Middle East & Africa Neurological Disorder Drugs Revenue by Countries (2015-2020) (USD Million)

Table 94. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Countries (2015-2020)

Table 95. Middle East & Africa Neurological Disorder Drugs Sales by Country (2020-2025) (K Units)

Table 96. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Country (2020-2025)

Table 97. Middle East & Africa Neurological Disorder Drugs Revenue by Country (2020-2025) (USD Million)

Table 98. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Country (2020-2025)

Table 99. United States Neurological Disorder Drugs Sales by Type (2015-2020) (K Units)

Table 100. United States Neurological Disorder Drugs Sales Market Share by Type (2015-2020)

Table 101. United States Neurological Disorder Drugs Revenue by Type (2015-2020) (USD Million)

Table 102. United States Neurological Disorder Drugs Revenue Market Share by Type (2015-2020)

Table 103. United States Neurological Disorder Drugs Sales by Type (2020-2025) (K Units)

Table 104. United States Neurological Disorder Drugs Sales Market Share by Type (2020-2025)

Table 105. United States Neurological Disorder Drugs Revenue by Type (2020-2025) (USD Million)

Table 106. United States Neurological Disorder Drugs Revenue Market Share by Type (2020-2025)

Table 107. Global Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)

Table 108. Global Neurological Disorder Drugs Sales Market Share by Application (2015-2020)

Table 109. Global Neurological Disorder Drugs Revenue by Application (2015-2020) (USD Million)

Table 110. Global Neurological Disorder Drugs Revenue Market Share by Application (2015-2020)

Table 111. Global Neurological Disorder Drugs Price by Application (2015-2020) (USD/Unit)

Table 112. Global Neurological Disorder Drugs Sales by Application (2020-2025) (K Units)

Table 113. Global Neurological Disorder Drugs Sales Market Share by Application (2020-2025)

Table 114. Global Neurological Disorder Drugs Revenue by Application (2020-2025) (USD Million)

Table 115. Global Neurological Disorder Drugs Revenue Market Share by Application (2020-2025)

Table 116. Global Neurological Disorder Drugs Price by Application (2020-2025) (USD/Unit)

Table 117. United States Neurological Disorder Drugs Sales by Application (2015-2020) (K Units)

Table 118. United States Neurological Disorder Drugs Sales Market Share by Application (2015-2020)

Table 119. United States Neurological Disorder Drugs Revenue by Application (2015-2020) (USD Million)

Table 120. United States Neurological Disorder Drugs Revenue Market Share by Application (2015-2020)

Table 121. United States Neurological Disorder Drugs Sales by Application (2020-2025) (K Units)

Table 122. United States Neurological Disorder Drugs Sales Market Share by Application (2020-2025)

Table 123. United States Neurological Disorder Drugs Revenue by Application (2020-2025) (USD Million)

Table 124. United States Neurological Disorder Drugs Revenue Market Share by Application (2020-2025)

Table 125. Direct Channel Pros & Cons

Table 126. Indirect Channel Pros & Cons

Table 127. Distributors/Traders/ Dealers List

Table 128. Customers of Neurological Disorder Drugs

Table 129. Market Opportunities in Next Few Years

Table 130. Market Risks Analysis

Table 131. Market Drivers

List of Figures

Figure 1. Neurological Disorder Drugs Picture

Figure 2. Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Antipsychotic Picture

Figure 4. Hypnotic & Sedative Picture

Figure 5. Analgesics Picture

Figure 6. Anticoagulants Picture

Figure 7. Others Picture

Figure 8. Neurological Disorder Drugs Sales Market Share by Application in 2019

Figure 9. Hospital Picture

Figure 10. Clinic Picture

Figure 11. Global Neurological Disorder Drugs Market Status and Outlook (2015-2025) (USD Million)

Figure 12. Global Neurological Disorder Drugs Sales Growth Rate (2015-2025) (K Units)

Figure 13. Global Neurological Disorder Drugs Sales Market Share by Manufacturer in 2019

Figure 14. Global Neurological Disorder Drugs Revenue Market Share by Manufacturer in 2019

Figure 15. Key Players Neurological Disorder Drugs Revenue Market Share in United States in 2019

Figure 16. Global Top 5 Neurological Disorder Drugs Manufacturer Market Share in 2019

Figure 17. Top 3 Neurological Disorder Drugs Players Market Share in United States in 2019

Figure 18. Global Neurological Disorder Drugs Revenue Market Share by Regions in 2019

Figure 19. North America Neurological Disorder Drugs Sales YoY Growth (2015-2025) (K Units)

Figure 20. North America Neurological Disorder Drugs Revenue YoY Growth (2015-2025) (USD Million)

Figure 21. Europe Neurological Disorder Drugs Sales YoY Growth (2015-2020) (K Units)

Figure 22. Europe Neurological Disorder Drugs Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. Asia-Pacific Neurological Disorder Drugs Sales YoY Growth (2015-2020) (K Units)

Figure 24. Asia-Pacific Neurological Disorder Drugs Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. South America Neurological Disorder Drugs Sales YoY Growth (2015-2020) (K Units)

Figure 26. South America Neurological Disorder Drugs Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. Middle East & Africa Neurological Disorder Drugs Sales YoY Growth (2015-2020) (K Units)

Figure 28. Middle East & Africa Neurological Disorder Drugs Revenue YoY Growth (2015-2020) (USD Million)

Figure 29. North America Neurological Disorder Drugs Sales Market Share by Country in 2019

Figure 30. North America Neurological Disorder Drugs Revenue Market Share by Country in 2019

Figure 31. United States Neurological Disorder Drugs Market Size and Growth Rate (2015-2025) (USD Million)

Figure 32. Canada Neurological Disorder Drugs Market Size and Growth Rate (2015-2025) (USD Million)

Figure 33. Mexico Neurological Disorder Drugs Market Size and Growth Rate (2015-2020) (USD Million)

Figure 34. Europe Neurological Disorder Drugs Revenue Market Share by Country in 2019

Figure 35. Germany Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. United Kingdom Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. France Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Russia Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 39. Italy Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 40. Asia-Pacific Neurological Disorder Drugs Sales Market Share by Region 2018

Figure 41. Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Region 2018

Figure 42. China Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. Japan Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Korea Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. India Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. Southeast Asia Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 47. Australia Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 48. South America Neurological Disorder Drugs Sales Market Share by Country in 2019

Figure 49. South America Neurological Disorder Drugs Revenue Market Share by Country in 2019

Figure 50. Brazil Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Argentina Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Saudi Arabia Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. Turkey Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Egypt Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 55. South Africa Neurological Disorder Drugs Market Size Growth Rate (2015-2025) (USD Million)

Figure 56. Global Revenue Market Share of Neurological Disorder Drugs by Type in 2019

Figure 57. Global Revenue Market Share of Neurological Disorder Drugs by Application in 2019

Figure 58. Sales Channel: Direct Channel vs Indirect Channel